
Investing.com – Israel stocks were lower after the close on Tuesday, as losses in the Insurance, Real Estate and Financials sectors led shares lower.
At the close in Tel Aviv, the TA 35 lost 0.54%.
The best performers of the session on the TA 35 were Teva Pharmaceutical Industries Ltd (TASE:TEVA), which rose 4.50% or 192.00 points to trade at 4,461.00 at the close. Meanwhile, Camtek Ltd (TASE:CAMT) added 1.55% or 450.00 points to end at 29,480.00 and ICL Israel Chemicals Ltd (TASE:ICL) was up 0.71% or 12.00 points to 1,710.00 in late trade.
The worst performers of the session were Azrieli Group Ltd (TASE:AZRG), which fell 3.72% or 920.00 points to trade at 23,780.00 at the close. Elbit Systems Ltd (TASE:ESLT) declined 3.25% or 2,560.00 points to end at 76,110.00 and Newmed Energy LP (TASE:NWMDp) was down 3.11% or 30.00 points to 933.00.
Falling stocks outnumbered advancing ones on the Tel Aviv Stock Exchange by 288 to 160 and 89 ended unchanged.
Shares in Teva Pharmaceutical Industries Ltd (TASE:TEVA) rose to 3-years highs; gaining 4.50% or 192.00 to 4,461.00. Shares in Camtek Ltd (TASE:CAMT) rose to all time highs; up 1.55% or 450.00 to 29,480.00.
Crude oil for March delivery was down 0.24% or 0.18 to $74.58 a barrel. Elsewhere in commodities trading, Brent oil for delivery in March fell 0.37% or 0.30 to hit $79.76 a barrel, while the February Gold Futures contract rose 0.24% or 4.95 to trade at $2,027.15 a troy ounce.
USD/ILS was unchanged 0.13% to 3.76, while EUR/ILS fell 0.54% to 4.07.
The US Dollar Index Futures was up 0.38% at 103.51.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.